INTERNATIONAL BIOTECHNOLOGY TRUST PLC - RELMADA THERAPEUTICS INC ownership

RELMADA THERAPEUTICS INC's ticker is RLMD and the CUSIP is 75955J402. A total of 145 filers reported holding RELMADA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 2.08 and the average weighting 0.5%.

Quarter-by-quarter ownership
INTERNATIONAL BIOTECHNOLOGY TRUST PLC ownership history of RELMADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$30,000
+21.5%
10,0000.0%0.01%
+25.0%
Q2 2023$24,700
+9.8%
10,0000.0%0.01%
+33.3%
Q1 2023$22,500
-35.5%
10,0000.0%0.01%
-45.5%
Q4 2022$34,900
-90.6%
10,0000.0%0.01%
-90.8%
Q3 2022$370,000
-96.3%
10,000
+5163.2%
0.12%
+14.4%
Q2 2022$10,000,000
+1249.5%
190
-98.1%
0.10%
-37.7%
Q1 2022$741,000
+229.3%
10,0000.0%0.17%
+234.0%
Q4 2021$225,000
-13.8%
10,0000.0%0.05%
-20.6%
Q3 2021$261,00010,0000.06%
Other shareholders
RELMADA THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Guild Investment Management, Inc. 205,300$615,9001.03%
Deep Track Capital, LP 2,837,818$8,513,4540.33%
PARSONS CAPITAL MANAGEMENT INC/RI 974,082$2,922,2460.23%
apricus wealth, LLC 77,362$239,8220.21%
Palo Alto Investors LP 732,400$2,197,2000.21%
RTW INVESTMENTS, LP 2,131,835$6,395,5050.14%
SILVERARC CAPITAL MANAGEMENT, LLC 100,000$300,0000.09%
AdvisorShares Investments LLC 112,908$338,7240.09%
Savior LLC 3,500$10,5000.07%
Spotlight Asset Group, Inc. 20,000$60,0000.05%
View complete list of RELMADA THERAPEUTICS INC shareholders